Partners Capital Investment Group’s Alexion Pharmaceuticals ALXN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-170,043	Closed	-$26.6M	–	157
2020 Q4	$26.6M	Buy	170,043 +4,577	+3%	+$588K	1.52%	21
2020 Q3	$18.9M	Buy	165,466 +25,476	+18%	+$2.75M	1.17%	29
2020 Q2	$15.7M	Buy	139,990 +36,303	+35%	+$3.85M	0.77%	36
2020 Q1	$9.31M	Buy	103,687 +30,251	+41%	+$2.97M	0.64%	39
2019 Q4	$7.94M	Buy	73,436 +1,828	+3%	+$196K	0.6%	46
2019 Q3	$7.01M	Buy	71,608 +19,728	+38%	+$2.22M	0.61%	48
2019 Q2	$6.79M	Buy	51,880 +4,451	+9%	+$574K	0.68%	46
2019 Q1	$6.41M	Buy	47,429 +5,402	+13%	+$672K	0.63%	41
2018 Q4	$4.09M	Buy	42,027 +13,790	+49%	+$1.63M	0.49%	52
2018 Q3	$3.92M	Buy	28,237 +3,644	+15%	+$457K	0.42%	47
2018 Q2	$3.05M	Buy	24,593 +5,099	+26%	+$596K	0.39%	49
2018 Q1	$2.17M	Buy	19,494 +10,661	+121%	+$1.27M	0.29%	52
2017 Q4	$1.06M	Buy	8,833 +4,400	+99%	+$536K	0.17%	51
2017 Q3	$622K	Buy	+4,433	New	+$602K	0.1%	45